Volume 3, Supplement 1SupplementRecent Clinical Studies of New Pharmacologic Agents and Their Efficacy in the Treatment of IncontineRodney A AppellOveractive bladderUrge incontinenceOxybutyninTolterodineAnticholinergic
Volume 3, Supplement 1SupplementFuture Trends in the Treatment of Urinary IncontinenceMichael B ChancellorUrinary incontinenceCapsaicinGene therapyAfferent blockadeAnticholinergicChili pepperNeurokinin · Overactive bladderResiniferitoxin
Volume 3, Supplement 1SupplementPotential Targets in the Treatment of Urinary IncontinenceWilliam SteersOveractive bladderUrge incontinenceNerve growth factorReceptor blockadeNeuroplasticityNeurotransmitter
Volume 4, Supplement 5SupplementReducing the Risk of Benign Prostatic Hyperplasia ProgressionClaus G RoehrbornBenign prostatic hyperplasiaFinasterideAcute urinary retentionLower
Volume 4, Supplement 5SupplementThe Potential for Prostate Cancer ChemopreventionOtis W BrawleyProstate cancerChemopreventionFinasteride5-reductaseAndrogens
Volume 4, Supplement 5SupplementRisk Factors for Prostate CancerPeter H GannProstatic neoplasmsRisk factorsEpidemiology
Volume 4, Supplement 5SupplementOpportunities for Prevention of Prostate Cancer: Genetics, Chemoprevention, and Dietary InterventionEric A KleinProstate cancerPreventionChemopreventionGeneticsDietary supple-